There's one Republican who's not as wealthy today as he was yesterday:

"The stock value of the Australian biotech firm Rep. Chris Collins championed to fellow lawmakers plummeted on Tuesday, costing the New York Republican $17 million as investigators continue probing his relationship with the firm. Innate Immunotherapeutic shares dropped more than 90 percent on Tuesday to 5 cents when markets closed in Australia. The tumultuous fall of the company's stock followed an announcement that the firm's star pharmaceutical drug for multiple sclerosis failed to pass clinical trials. Collins’ relationship with the company has raised eyebrows in recent months. And the Office of Government Ethics is currently investigating whether Collins engaged in insider trading." -- Politico